Most of the money goes into an investment account, and eventually to biotech/nanotech research to reanimate the patient. Most of the work in reanimating the pat

Most of the money goes into an investment account, and eventually to biotech/nanotech research to reanimate the patient. Most of the work in reanimating the patient is repairing extreme brain damage (from cold and ischemia). Repairing brain damage is extremely valuable to people who suffer from it, and to society. Sure there are more direct ways to fund brain damage research, but you don't get the same motivation; this feels like a selfish benefit to the person who spends on it so it is more likely to compete with luxuries instead of charitable causes.